Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "6890aa548a215c65672372e1",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "EMPATECH LINA 25/5",
"description": "EMPATECH LINA 25/5 is a pharmaceutical tablet containing a combination of two active ingredients: Empagliflozin 25MG and Linagliptin 5MG. This medication is designed to help manage blood sugar levels in adults with type 2 diabetes mellitus. The combination works through complementary mechanisms to improve glycemic control more effectively than either drug alone. Empagliflozin is a sodium-glucose cotransporter-2 (SGLT2) inhibitor that promotes the excretion of excess glucose through urine, while Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and suppresses glucagon release, particularly after meals. EMPATECH LINA 25/5 is generally prescribed alongside a balanced diet and regular exercise to optimize blood sugar management and reduce the risk of diabetes-related complications such as kidney damage, neuropathy, and cardiovascular issues.\n\nWhat is EMPATECH LINA 25/5?\n\nEMPATECH LINA 25/5 is a prescription medication combining Empagliflozin (25MG) and Linagliptin (5MG) tablets used to manage type 2 diabetes. It helps control elevated blood sugar levels by using dual actions — the removal of glucose via kidneys and improving pancreatic hormone responses. This combination aims to achieve better and sustained glycemic control, often necessary for patients who have inadequate blood sugar control with other treatments.\n\nUses of EMPATECH LINA 25/5\n\nTo improve blood sugar control in adults with type 2 diabetes, particularly when monotherapy is insufficient.\n\nOften used as a second-line therapy after metformin or when metformin is not tolerated.\n\nTo reduce HbA1c (hemoglobin A1c), an important measure of long-term glucose control.\n\nMay help reduce weight and blood pressure as empagliflozin aids in glucose excretion.\n\nSupports comprehensive diabetes management along with diet and exercise.\n\nPrevents or reduces the risk of diabetes-associated complications such as kidney disease, cardiovascular events, and nerve damage.\n\nSide Effects of EMPATECH LINA 25/5\n\nCommon side effects may include urinary tract infections and genital infections due to increased glucose in urine.\n\nIncreased urination and dehydration.\n\nDizziness or lightheadedness, especially when standing up quickly.\n\nHypoglycemia (low blood sugar), though rare with this combination.\n\nGastrointestinal symptoms such as nausea or diarrhea.\n\nPotential increased risk of ketoacidosis (a serious condition related to high blood acids) in rare cases.\n\nAllergic reactions, although uncommon, may occur and require prompt medical attention.\n\nPrecautions Before Using EMPATECH LINA 25/5\n\nInform your healthcare provider if you have kidney disease, liver problems, or a history of urinary tract infections.\n\nNot recommended for type 1 diabetes or diabetic ketoacidosis treatment.\n\nUse with caution if you are pregnant, planning to become pregnant, or breastfeeding.\n\nStay hydrated while on this medication to reduce the risk of dehydration and dizziness.\n\nInform your doctor about any history of pancreatitis or pancreas disorders.\n\nRegular monitoring of kidney function and blood sugar levels is advised during treatment.\n\nAvoid drinking excessive alcohol as it may increase side effects or risk of ketoacidosis.\n\nDrug Interactions: What Drugs Interact with EMPATECH LINA 25/5?\n\nOther antidiabetic medications, such as insulin or sulfonylureas, may increase the risk of hypoglycemia.\n\nDiuretics, blood pressure medications, and lithium may interact and increase side effects.\n\nDrugs that impair kidney function can affect empagliflozin’s efficacy and safety.\n\nCertain enzyme-inducing drugs may reduce linagliptin levels, lowering its effectiveness.\n\nConsult your healthcare provider for a full list of possible interactions and before starting any new medication, including over-the-counter drugs or supplements.\n\nConclusion\n\nEMPATECH LINA 25/5, containing Empagliflozin 25MG and Linagliptin 5MG, is an effective combination medication to treat high blood sugar levels caused by type 2 diabetes. Its dual-action approach targets different physiological mechanisms to improve blood glucose control, helping reduce the risks and complications associated with diabetes. While it is generally well-tolerated, awareness of possible side effects and drug interactions is important. Always use under medical supervision, alongside lifestyle modifications such as diet and exercise, for optimal diabetes management.",
"price": 345.0,
"discountamount": 104.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2154,
"imageuri": "https://productimages.withfloats.com/actual/6890aa58dd0bc098c3220f4c.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6890aa58dd0bc098c3220f4c.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-08-04T12:40:52.619Z",
"updatedon": "2025-08-04T12:40:52.619Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/empatech-lina-25-5/2154",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Empagliflozin and Linagliptin Tablets",
"category": "DIABETIC RANGE",
"tags": [
"Empagliflozin and Linagliptin Tablets"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "685bf1b58f1119e73c154485",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "REBAMPEE OTIC",
"description": "REBAMPEE OTIC is an advanced nutraceutical formulation combining rebamipide, alpha lipoic acid, and acetylcysteine, uniquely designed to support inner ear health and manage age-related hearing loss. The synergistic combination of these three active ingredients works to reduce oxidative stress, prevent cellular degeneration, and support nerve function, offering a targeted solution in cases where oxidative damage contributes to auditory decline. The formulation, known as rebamipide alpha 100mg lipoic acid 100mg and acetylcysteine 100mg capsules, is gaining attention in otolaryngology as a supportive therapy for managing sensorineural and degenerative hearing conditions.\n\nWhat is REBAMPEE OTIC?\nREBAMPEE OTIC is a capsule formulation composed of three clinically significant ingredients:\n\nRebamipide (100 mg): Known for its mucosal protective and antioxidant properties, it plays a role in reducing inflammation and protecting the delicate inner ear structures from oxidative damage.\n\nAlpha Lipoic Acid (100 mg): A powerful antioxidant that supports nerve regeneration and protects against cellular degeneration in the cochlea and auditory pathways.\n\nAcetylcysteine (100 mg): An effective mucolytic and precursor to glutathione, it combats oxidative stress and may help reduce cochlear damage due to noise, drugs, or aging.\n\nTogether, they act to protect and rejuvenate auditory cells, making REBAMPEE OTIC a promising aid in the treatment and management of age-related hearing loss and oxidative stress-induced otological damage.\n\nUses of REBAMPEE OTIC\nUsed in the treatment of age-related hearing loss (presbycusis)\n\nHelps protect auditory nerve cells from oxidative damage\n\nSupports cochlear and inner ear health in degenerative auditory conditions\n\nMay aid in managing hearing impairment due to noise exposure or ototoxic medications\n\nPromotes antioxidant activity and inner ear cellular regeneration\n\nPossible Side Effects\nMost people tolerate REBAMPEE OTIC well, but some may experience mild to moderate side effects such as:\n\nNausea\n\nMild headache\n\nHeartburn\n\nDizziness\n\nAbdominal discomfort\n\nFatigue\n\nSerious Side Effects (Rare)\nIn rare cases, more severe effects may occur:\n\nAllergic reactions such as skin rash, itching, or swelling\n\nSevere abdominal pain\n\nBreathing difficulty or tightness in the chest\n\nSevere dizziness or fainting\n\nHepatic enzyme elevation or liver dysfunction\n\nSeek immediate medical attention if any serious symptoms occur.\n\nPrecautions Before Using REBAMPEE OTIC\nConsult your physician before starting if you have liver disease, kidney dysfunction, or any autoimmune condition\n\nNot recommended during pregnancy or breastfeeding unless prescribed by a doctor\n\nUse with caution in individuals with a known allergy to any of the ingredients\n\nAvoid excessive alcohol consumption during the course as it may increase liver stress\n\nNot to be used as a replacement for medically prescribed treatments for hearing loss without a physician’s recommendation\n\nDrug Interactions\nREBAMPEE OTIC may interact with several medications. It is important to inform your healthcare provider about all drugs you are currently taking, including supplements and herbal products.\n\nWhat drugs interact with REBAMPEE OTIC?\n\nAnticoagulants (e.g., warfarin): Alpha lipoic acid may enhance the anticoagulant effect, increasing the risk of bleeding\n\nAntidiabetic medications: May enhance the glucose-lowering effect, increasing the risk of hypoglycemia\n\nIron supplements: Acetylcysteine may interact with iron metabolism\n\nCertain antibiotics: NAC (acetylcysteine) may reduce the efficacy of some antibiotics if taken simultaneously\n\nThyroid medications: Alpha lipoic acid may interfere with thyroid hormone levels\n\nCisplatin and aminoglycoside antibiotics: When used with antioxidants like NAC, ototoxicity might be reduced, but consult your doctor for adjusted therapy\n\nAlways consult your doctor or pharmacist before combining REBAMPEE OTIC with other medications.\n\nConclusion\nREBAMPEE OTIC is a scientifically developed capsule combining rebamipide, alpha lipoic acid, and acetylcysteine, each known for its distinct cellular protective roles. When used as directed, this formula helps mitigate the effects of age-related hearing loss and supports inner ear health through potent antioxidant action. Safe, effective, and based on evidence-backed ingredients, REBAMPEE OTIC offers new hope for those experiencing the early signs of auditory decline.",
"price": 280.0,
"discountamount": 84.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": [
"reduce absorption",
"rebamipide 100mg",
"gastrointestinal issues",
"vasodilators caution",
"drugs interact",
"worsens consult",
"liver enzymes",
"promote healing",
"chronic conditions",
"chronic inflammation",
"individuals suffering",
"lasting relief",
"acetylcysteine 100mgtargeting",
"wellbalanced combination",
"activated charcoal",
"respiratory sensitivity",
"breastfeeding womenonly",
"kidney disorders",
"precautions inform",
"symptom persists",
"side effects",
"rare cases",
"taste due",
"diarrhea headache",
"generally welltolerated",
"burning sensation",
"tingling numbness",
"metabolic disorders",
"oxidative stress",
"ulcers reduction",
"gastric mucosa",
"diabetic neuropathy",
"neurological protection",
"oxidative damage",
"powerful mucolytic",
"universal antioxidant",
"multifunctional capsule",
"ideal adjunct",
"tripleaction formulation",
"neuroprotective properties",
"antioxidant mucosalprotective",
"cellular health",
"mucosal protection",
"nerve health",
"healthcare provider",
"medications antacids",
"antioxidant agent",
"rebampee otic",
"starting rebampee otic",
"rebampee oticrebampee otic",
"medical supervision patients",
"healthcare professional precautions",
"acetylcysteine temporary increase",
"mucosal protective agent",
"medications herbal supplements",
"cellular defense making",
"supports nerve regeneration",
"doctors dosage instructions",
"optimal results follow",
"simultaneously iron supplements",
"dizziness skin rash",
"ingredients work synergistically"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2137,
"imageuri": "https://productimages.withfloats.com/actual/685bf1b95d6f047570824865.png",
"tileimageuri": "https://productimages.withfloats.com/tile/685bf1b95d6f047570824865.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-06-25T12:55:17.97Z",
"updatedon": "2025-07-02T06:35:37.588Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/rebampee-otic/2137",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "rebamipide alpha lipoic acid and acetylcysteine capsules",
"category": "GASTROLOGYRANGE",
"tags": [
"rebamipide alpha lipoic acid and acetylcysteine capsules",
"rebamipide tablets uses in hindi"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "668e8611b9f7300708fe1240",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "TRIOGLIMITERIS 1/0.2 ",
"description": "TRIOGLIMITERIS 1/0.2 \nVoglibose 0.2 mg, Glimepiride 1 mg & Metformin Hydrochloride 500 mg\nIntroduction\n\nTRIOGLIMITERIS 1/0.2 is a combination medication containing Voglibose, Glimepiride, and Metformin Hydrochloride. It is primarily used in the management of type 2 diabetes mellitus to improve glycemic control through different mechanisms of action targeting glucose metabolism.\n\nComposition\n\nVoglibose (0.2 mg): An alpha-glucosidase inhibitor that delays the digestion of carbohydrates in the intestine, thereby reducing postprandial blood glucose levels.\nGlimepiride (1 mg): A sulfonylurea derivative that stimulates insulin release from pancreatic beta cells, enhancing glucose uptake in peripheral tissues.\nMetformin Hydrochloride (500 mg): A biguanide that decreases hepatic glucose production, improves insulin sensitivity in peripheral tissues, and reduces intestinal glucose absorption.\nMechanism of Action\n\nTRIOGLIMITERIS 1/0.2 combines the actions of its components to achieve optimal glycemic control:\n\nVoglibose: Inhibits alpha-glucosidase enzymes in the intestine, delaying carbohydrate digestion and reducing the absorption of glucose after meals.\nGlimepiride: Stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner, thereby lowering blood glucose levels.\nMetformin Hydrochloride: Decreases hepatic glucose production through suppression of gluconeogenesis and enhances peripheral glucose uptake and utilization by improving insulin sensitivity.\nIndications\n\nTRIOGLIMITERIS 1/0.2 is indicated for:\n\nType 2 Diabetes Mellitus: Used to improve glycemic control in adults when diet, exercise, and monotherapy with metformin or sulfonylureas alone are not sufficient.\nDosage and Administration\n\nThe typical dosage of TRIOGLIMITERIS 1/0.2 is one tablet taken orally with meals, usually once or twice daily.\nDosage adjustments may be required based on individual patient response, blood glucose levels, and renal function.\nIt is essential to adhere to the prescribed dosage regimen to achieve optimal therapeutic outcomes.\nSide Effects\n\nCommon side effects of TRIOGLIMITERIS 1/0.2 may include:\n\nHypoglycemia (especially when used in combination with insulin or other antidiabetic medications)\nGastrointestinal disturbances (such as nausea, vomiting, diarrhea, or abdominal discomfort)\nWeight gain (mainly associated with sulfonylureas)\nMore severe side effects can include:\n\nAllergic reactions (rash, itching, swelling)\nLactic acidosis (rare but serious adverse effect associated with metformin use)\nHepatic dysfunction (monitor liver function tests periodically)\nPrecautions\n\nUse with caution in patients with renal impairment, hepatic dysfunction, or other significant medical conditions that may affect drug metabolism or excretion.\nRegular monitoring of blood glucose levels, renal function, and liver function is recommended during treatment with TRIOGLIMITERIS 1/0.2.\nAvoid use in patients with type 1 diabetes mellitus or diabetic ketoacidosis.\nDrug Interactions\n\nTRIOGLIMITERIS 1/0.2 may interact with other medications affecting blood glucose levels, such as insulin, other oral antidiabetic agents, or drugs that affect renal function or hepatic metabolism. Close monitoring and dose adjustments may be necessary.\nConclusion\n\nTRIOGLIMITERIS 1/0.2 provides a comprehensive approach to managing type 2 diabetes mellitus by combining Voglibose, Glimepiride, and Metformin Hydrochloride. This combination targets different aspects of glucose metabolism, enhancing insulin secretion, reducing hepatic glucose production, and delaying carbohydrate absorption in the intestine. Proper dosage, administration, and monitoring for side effects are essential to achieve and maintain optimal glycemic control in diabetic patients using TRIOGLIMITERIS 1/0.2. Consultation with a healthcare provider is recommended for personalized treatment plans and management of diabetes with this medication.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n",
"price": 195.0,
"discountamount": 58.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"500 mg",
"0.2 mg",
"one tablet",
"Weight gain",
"Glimepiride 1",
"metformin use",
"Proper dosage",
"Glimepiride (1",
"dosage regimen",
"typical dosage",
"renal function",
"insulin release",
"drug metabolism",
"Lactic acidosis",
"Close monitoring",
"dose adjustments",
"renal impairment",
"diabetic patients",
"insulin secretion",
"different aspects",
"Drug Interactions",
"other medications",
"Regular monitoring",
"Dosage adjustments",
"Allergic reactions",
"peripheral tissues",
"hepatic metabolism",
"glucose metabolism",
"insulin sensitivity",
"healthcare provider",
"Hepatic dysfunction",
"Common side effects",
"abdominal discomfort",
"different mechanisms",
"liver function tests",
"diabetic ketoacidosis",
"pancreatic beta cells",
"combination medication",
"carbohydrate digestion",
"comprehensive approach",
"serious adverse effect",
"Metformin Hydrochloride",
"carbohydrate absorption",
"sulfonylurea derivative",
"glucose-dependent manner",
"optimal glycemic control",
"type 1 diabetes mellitus",
"type 2 diabetes mellitus",
"More severe side effects",
"alpha-glucosidase enzymes",
"peripheral glucose uptake",
"hepatic glucose production",
"alpha-glucosidase inhibitor",
"individual patient response",
"personalized treatment plans",
"optimal therapeutic outcomes",
"Gastrointestinal disturbances",
"intestinal glucose absorption",
"other antidiabetic medications",
"other oral antidiabetic agents",
"postprandial blood glucose levels",
"other significant medical conditions"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1939,
"imageuri": "https://productimages.withfloats.com/actual/668e86143a68154e11e7d822.jpeg",
"tileimageuri": "https://productimages.withfloats.com/tile/668e86143a68154e11e7d822.jpeg",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-07-10T13:01:05.875Z",
"updatedon": "2024-07-10T13:01:05.875Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/trioglimiteris-1-0-2-/1939",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "TRIOGLIMITERIS 1/0.2 ",
"category": "DIABETIC RANGE",
"tags": [
"glimepiride 1mg+metformin 500mg+voglibose 0.2 mg",
"Glimepiride 2mg Metformin 500mg Voglibose 0.2 mg b",
"glimepiride 2mg+metformin 500mg+voglibose 0.2 mg",
"voglibose glimepiride & metformin hydrochloride (s",
"voglibose glimepiride + metformin hydrochloride us",
"glimepiride 1mg+metformin 500mg+voglibose 0.3 mg",
"glimepiride 2mg+metformin 500mg+voglibose 0.2 mg g",
""
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6662aa04db100e1fdc2dcb68",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "VILDIABATE 100 ",
"description": "VILDIABATE 100 \nVildagliptin (100mg)\nVILDIABATE 100 is a medication designed to manage type 2 diabetes mellitus by targeting specific aspects of glucose regulation. It contains Vildagliptin, an oral antidiabetic agent that belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors. Vildagliptin works by inhibiting the enzyme DPP-4, which is responsible for degrading incretin hormones like GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide).\n\nHere are key points about VILDIABATE 100:\n\nMechanism of Action: Vildagliptin acts by inhibiting DPP-4, thereby increasing the levels of GLP-1 and GIP. These hormones play crucial roles in glucose metabolism:\n\nGLP-1 stimulates insulin secretion from pancreatic beta cells in a glucose-dependent manner. It also inhibits glucagon secretion, reduces appetite, and slows gastric emptying.\nGIP enhances insulin release in response to meals, contributing to postprandial glucose control.\nBlood Sugar Control: By enhancing insulin secretion and reducing glucagon levels, VILDIABATE 100 helps lower blood sugar levels, especially after meals. This mechanism targets both fasting and postprandial hyperglycemia, contributing to overall glycemic control.\n\nDosage and Administration: VILDIABATE 100 is typically taken orally once daily, preferably with a meal to maximize its effects on postprandial glucose levels. The dosage may vary depending on individual needs and response to treatment. It's essential to follow your healthcare provider's instructions regarding dosage and timing.\n\nEfficacy and Safety: Clinical studies have demonstrated the efficacy of Vildagliptin in lowering HbA1c levels (a marker of long-term glucose control) and improving glycemic parameters. It is generally well-tolerated, with common side effects including headache, nasopharyngitis (inflammation of the nose and throat), and upper respiratory tract infections. Serious side effects are rare but may include pancreatitis or hypersensitivity reactions.\n\nCombination Therapy: VILDIABATE 100 may be prescribed as monotherapy or in combination with other antidiabetic medications such as metformin or sulfonylureas. Combining medications with different mechanisms of action can provide synergistic benefits in managing diabetes.\n\nMonitoring and Follow-Up: Regular monitoring of blood sugar levels, kidney function, and other relevant parameters is important during treatment with VILDIABATE 100. Your healthcare provider may adjust the dosage or add/modify other medications based on your response and individual needs.\n\nLifestyle Modifications: In addition to medication, lifestyle modifications such as a healthy diet, regular exercise, weight management, and avoiding tobacco and excessive alcohol intake are essential components of diabetes management.\n\nIn conclusion, VILDIABATE 100 containing Vildagliptin is an effective oral antidiabetic medication that helps regulate blood sugar levels in patients with type 2 diabetes. It acts by enhancing insulin secretion and reducing postprandial glucose levels, contributing to improved glycemic control. However, it should be used under medical supervision, and adherence to prescribed dosage and lifestyle recommendations is crucial for optimal diabetes management.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order Now\nhttps://www.sterisonline.com/product/vildiabate-100-133452\n\n\n\n\n\n",
"price": 275.0,
"discountamount": 82.5,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 7,
"_keywords": [
"GIP",
"nose",
"GLP-1",
"EMAIL",
"class",
"meals",
"Order",
"timing",
"throat",
"enzyme",
"Safety",
"Dosage",
"marker",
"tobacco",
"fasting",
"response",
"addition",
"appetite",
"headache",
"patients",
"Efficacy",
"metformin",
"Follow-Up",
"adherence",
"treatment",
"VILDIABATE",
"conclusion",
"key points",
"information",
"monotherapy",
"healthy diet",
"instructions",
"sterisonline",
"pancreatitis",
"inflammation",
"sterispharma",
"HbA1c levels",
"CALL/WHATSAPP",
"sulfonylureas",
"crucial roles",
"Administration",
"insulin release",
"nasopharyngitis",
"kidney function",
"glucagon levels",
"gastric emptying",
"specific aspects",
"Clinical studies",
"individual needs",
"regular exercise",
"other medications",
"Vildagliptin acts",
"incretin hormones",
"DPP-4) inhibitors",
"weight management",
"insulin secretion",
"glucose metabolism",
"glucose regulation",
"glucagon secretion",
"blood sugar levels",
"Regular monitoring",
"Combination Therapy",
"glycemic parameters",
"common side effects",
"Blood Sugar Control",
"medical supervision",
"healthcare provider",
"essential components",
"synergistic benefits",
"different mechanisms",
"Serious side effects",
"pancreatic beta cells",
"dipeptidyl peptidase-4",
"oral antidiabetic agent",
"Lifestyle Modifications",
"glucose-dependent manner",
"excessive alcohol intake",
"overall glycemic control",
"type 2 diabetes mellitus",
"lifestyle recommendations",
"other relevant parameters",
"long-term glucose control",
"hypersensitivity reactions",
"postprandial hyperglycemia",
"optimal diabetes management",
"postprandial glucose levels",
"postprandial glucose control",
"other antidiabetic medications",
"upper respiratory tract infections",
"effective oral antidiabetic medication",
"glucose-dependent insulinotropic peptide"
],
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 1491,
"imageuri": "https://productimages.withfloats.com/actual/6662aa0b364f23242470b3ca.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6662aa0b364f23242470b3ca.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2024-06-07T06:34:44.056Z",
"updatedon": "2024-06-28T11:58:50.164Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/vildiabate-100-/1491",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "VILDIABATE 100 ",
"category": "DIABETIC RANGE",
"tags": [
"VILDIABATE 100",
"Vildagliptin (100mg)",
"Vildagliptin 100 mg uses",
"Vildagliptin 100 mg price",
"Vildagliptin 100 mg SR brand Name",
"Vildagliptin 100 mg brands in India",
"",
"Vildagliptin 100 mg generic medicine",
"Vildagliptin 100 mg side effects"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": "",
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68c29ba02244c906e7790e2b",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "TELAVINCE 300",
"description": "TELAVINCE 300 is a high-quality antiviral medication containing Tenofovir Disoproxil Fumarate 300 mg, specifically formulated for the effective management of HIV-1 infection and chronic Hepatitis B in adults and adolescents. Manufactured under strict pharmaceutical standards, TELAVINCE 300 offers consistent, potent, and clinically proven antiviral action, helping to suppress viral replication and improve immune function.\n\nTenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). It works by interfering with the enzyme reverse transcriptase, which is essential for viral replication in HIV and Hepatitis B viruses. By inhibiting this enzyme, TELAVINCE 300 reduces the amount of virus in the body, helping to prevent further immune system damage and liver complications.\n\n \nKey Indications:\n \n\nTELAVINCE 300 is indicated for:\n\nHIV-1 Infection: In combination with other antiretroviral agents for the treatment of HIV-1 in adults and adolescents (aged 12 years and older, weighing at least 35 kg).\n\nChronic Hepatitis B: For the treatment of chronic hepatitis B virus infection in adults and adolescents with compensated liver disease and evidence of active viral replication.\n\n \nMechanism of Action:\n \nTenofovir Disoproxil Fumarate is a prodrug of tenofovir, which, once absorbed and metabolized in the body, is converted into tenofovir diphosphate, the active form. Tenofovir diphosphate acts as a competitive inhibitor of reverse transcriptase, incorporating itself into the viral DNA chain and causing premature chain termination. This process disrupts the life cycle of the virus, significantly reducing its ability to multiply and spread.\n\n \nDosage and Administration:\n \n\nRecommended Dose for Adults and Adolescents (≥12 years, ≥35 kg): One tablet (300 mg) once daily, preferably with food.\n\nFor HIV Treatment: Administer in combination with other antiretroviral medications as per the treatment regimen.\n\nFor Chronic Hepatitis B: Monotherapy or as part of combination therapy, depending on patient condition and physician's assessment.\n\nDosage adjustments may be required in patients with renal impairment. Close monitoring is recommended for patients with existing kidney disease.\n\n \nKey Benefits of TELAVINCE 300:\n \n\nPotent Antiviral Action: Rapid and sustained suppression of HIV and HBV replication.\nOnce-Daily Dosing: Improves patient compliance and treatment adherence.\n\nBacked by Clinical Research: Proven efficacy in managing viral load and improving immune markers (CD4 count).\n\nTrusted Quality: Manufactured under GMP-certified facilities with stringent quality control processes.\n\nPart of First-Line Therapy: Recommended in various national and international treatment guidelines for HIV and Hepatitis B.\n\n \nSafety and Precautions:\n \n\nRenal Monitoring: Tenofovir may affect kidney function. Routine renal function tests are recommended before and during treatment.\n\nBone Mineral Density: Long-term use may reduce bone mineral density. Consider monitoring in patients at risk of osteopenia or osteoporosis.\n\nHepatic Flare: Discontinuation of therapy in hepatitis B patients may result in severe acute exacerbations. Liver function should be closely monitored post-treatment.\n\nLactic Acidosis and Hepatomegaly: Rare but serious side effects. Patients presenting symptoms such as abdominal pain, fatigue, or difficulty breathing should seek immediate medical attention.\n\n \n\nPossible Side Effects:\n \n\nMost patients tolerate TELAVINCE 300 well. However, some may experience:\n\nNausea\n\nDiarrhea\n\nHeadache\n\nFatigue\n\nRash\n\nDizziness\n\nDecreased bone mineral density\n\nRenal impairment (in rare cases)\n\nIf any side effects persist or worsen, consult a healthcare professional immediately.\n\n \nStorage Instructions:\n \n\nStore in a cool, dry place below 30°C.\n\nProtect from light and moisture.\n\nKeep out of reach of children.\n\n \n\nWhy Choose TELAVINCE 300?\n \n\nTELAVINCE 300 offers a dependable, clinically validated solution for the long-term management of HIV and Hepatitis B. With its once-daily dosing and proven effectiveness, TELAVINCE 300 is an ideal choice for patients and healthcare providers looking for quality, safety, and therapeutic reliability. It is manufactured by a trusted name in healthcare, ensuring every tablet meets global pharmaceutical standards.\n\n \nDisclaimer:\n \n\nThis product description is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or healthcare provider before starting any medication.",
"price": 1480.0,
"discountamount": 444.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2179,
"imageuri": "https://productimages.withfloats.com/actual/68c29ba3794abb27ab248d73.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68c29ba3794abb27ab248d73.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-09-11T09:51:28.508Z",
"updatedon": "2025-09-11T09:51:28.508Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/telavince-300/2179",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Tenofovir Disoproxil Fumarate Tablets ip 300 mg",
"category": "GENERAL RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68beb194933ec7924333073c",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "PYRITIGMIN RIVA 1.5",
"description": "Rivastigmine 1.5 mg capsule, marketed as PYRITIGMIN RIVA 1.5, is a prescription medication primarily used for the treatment of mild to moderate dementia associated with Alzheimer’s disease and Parkinson’s disease. It belongs to a class of drugs known as cholinesterase inhibitors, which work by increasing the levels of acetylcholine, a chemical messenger in the brain, to improve cognitive function, memory, and daily activities.\n\n \n\nComposition of Rivastigmine 1.5 mg Capsule\n \n\nActive Ingredient: Rivastigmine 1.5 mg\n\nBrand Name: PYRITIGMIN RIVA 1.5\n\nForm: Capsule\n\nCategory: Cholinesterase inhibitor\n\nManufacturer: Steris Healthcare\n\nEach capsule contains 1.5 mg of Rivastigmine, along with inactive excipients that help in capsule stability and absorption.\n\n \nWhat is Rivastigmine 1.5 mg?\n \n\nRivastigmine 1.5 mg is a central nervous system (CNS) acting drug used to treat cognitive decline in patients with Alzheimer’s and Parkinson’s disease dementia.\n\nIt inhibits the enzyme acetylcholinesterase, which breaks down acetylcholine in the brain.\n\nBy increasing acetylcholine levels, it enhances communication between nerve cells, improving memory, attention, and problem-solving skills.\n\nPYRITIGMIN RIVA 1.5 is suitable for patients who require a low starting dose, helping to minimize side effects during treatment initiation.\n\n \nUses of Rivastigmine 1.5 mg Capsules\n \n\nTreatment of Mild to Moderate Alzheimer’s Disease\n\nImproves cognitive function, memory, and daily activity performance.\n\nManagement of Parkinson’s Disease Dementia\n\nHelps in improving memory, attention, and behavioral symptoms.\n\nSupportive Therapy for Cognitive Decline\n\nSlows the progression of dementia-related symptoms.\n\n \nDosage and Administration\n \n\nStarting Dose: 1.5 mg capsule twice daily (morning and evening) or as prescribed by a doctor.\nCapsules should be swallowed whole with water, preferably after meals to reduce gastrointestinal side effects.\n\nDose may be gradually increased based on tolerance and clinical response.\n\nRegular monitoring of weight, appetite, and cognitive function is recommended during therapy.\n\n \nBenefits of Rivastigmine 1.5 mg Capsules\n \n\nImproves memory and cognitive function\n\nEnhances daily living activities in dementia patients\n\nReduces behavioral and psychiatric symptoms associated with Alzheimer’s and Parkinson’s dementia\n\nProvides gradual symptom management with minimal side effects when initiated at low doses\n\nPYRITIGMIN RIVA 1.5 is patient-friendly due to its low starting dose\n\n \nSide Effects of Rivastigmine 1.5 mg Capsules\n \n\nWhile generally well-tolerated, some patients may experience mild to moderate side effects:\n\nNausea and vomiting\n\nLoss of appetite or weight loss\n\nDiarrhea\n\nDizziness or headache\n\nFatigue\n\nTremors\n\nSerious side effects (rare) include:\n\nSevere vomiting or dehydration\n\nAllergic reactions (rash, swelling, difficulty breathing)\n\nHeart rhythm changes (bradycardia)\n\nPatients should inform their doctor if any severe or persistent side effects occur.\n\n \nPrecautions Before Using Rivastigmine 1.5 mg\n \n\nInform your doctor if you have heart disease, liver problems, kidney disease, or stomach ulcers.\n\nUse with caution in patients prone to fainting or low blood pressure.\n\nNot recommended during pregnancy or breastfeeding unless prescribed by a healthcare provider.\n\nAvoid sudden discontinuation of medication to prevent worsening of cognitive symptoms.\n\nMonitor for gastrointestinal issues and maintain hydration during therapy.\n\n \nDrug Interactions\n \n\nRivastigmine may interact with certain medications:\n\nCholinergic drugs (e.g., pilocarpine, bethanechol) – may increase cholinergic effects\n\nAnticholinergic drugs (e.g., atropine, scopolamine) – may reduce Rivastigmine’s effectiveness\n\nBeta-blockers or antiarrhythmics – may increase risk of slow heart rate\n\nNSAIDs or anticoagulants – monitor for gastrointestinal bleeding\n\nAlways inform your healthcare provider about all medications, supplements, and herbal products you are taking.\n\n \nConclusion\n \n\nRivastigmine 1.5 mg Capsules (PYRITIGMIN RIVA 1.5) are an effective treatment for cognitive decline associated with Alzheimer’s and Parkinson’s dementia.Always use Rivastigmine 1.5 mg under medical supervision, and follow prescribed dosage and lifestyle recommendations to achieve optimal cognitive support.",
"price": 192.0,
"discountamount": 58.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2176,
"imageuri": "https://productimages.withfloats.com/actual/68beb197484e8a57b992d471.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68beb197484e8a57b992d471.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-09-08T10:36:04.37Z",
"updatedon": "2025-09-08T10:36:04.37Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/pyritigmin-riva-1-5/2176",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "rivastigmine 1.5 mg capsule",
"category": "",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68bc22e83c3803d861d696a9",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "CEPHODOXIAA 200",
"description": "CEPHODOXIAA 200 is a broad-spectrum oral antibiotic from Steris Healthcare Pvt. Ltd., containing Cefpodoxime Proxetil 200 mg. It belongs to the third-generation cephalosporin class, designed to combat a wide range of bacterial infections effectively. With its high bioavailability, safety profile, and proven efficacy, it is trusted in clinical practice for managing both respiratory and urinary tract infections.\n\nUsage and Benefits\nCEPHODOXIAA 200 is prescribed for the treatment of bacterial infections caused by susceptible microorganisms, including:\n\nRespiratory tract infections (bronchitis, pneumonia, sinusitis, pharyngitis, tonsillitis)\n\nUrinary tract infections (cystitis, pyelonephritis)\n\nEar infections (otitis media)\n\nSkin and soft tissue infections\n\nCertain sexually transmitted infections (like gonorrhea)\n\nCommunity-acquired infections where cephalosporins are indicated\n\nBenefits:\n\nBroad-spectrum antibacterial activity against gram-positive and gram-negative organisms\n\nHigh tolerability and oral bioavailability\n\nConvenient twice-daily dosing\n\nEffective alternative when resistance to other antibiotics is suspected\n\nDosage and Administration\nAdults: Typical dose is 200 mg every 12 hours, depending on the severity of the infection.\n\nChildren: Dose is weight-adjusted, usually prescribed in suspension form.\n\nDuration: Treatment typically lasts 5–14 days depending on the infection type and clinical response.\n\nAdministration Tips:\n\nTake with food to enhance absorption.\n\nComplete the full course even if symptoms improve early.\n\nDo not double the dose if a dose is missed—take it as soon as remembered unless it is nearly time for the next dose.\n\nSide Effects\nLike all medicines, CEPHODOXIAA 200 may cause mild to moderate side effects. Common ones include:\n\nGastrointestinal upset (nausea, diarrhea, abdominal pain)\n\nHeadache or dizziness\n\nSkin rash or itching\n\nRare but serious side effects:\n\nSevere allergic reactions (swelling, difficulty breathing)\n\nPseudomembranous colitis (persistent diarrhea)\n\nLiver enzyme elevations\n\nDrug Interactions\nAntacids & H2 blockers: May reduce absorption of Cefpodoxime. Take at least 2–3 hours apart.\n\nBlood thinners (e.g., warfarin): May increase risk of bleeding.\n\nOther antibiotics: Avoid concurrent use unless directed by a doctor to prevent resistance.\n\nAlways inform your physician of all medications and supplements you are taking before starting therapy.\n\nConclusion\nCEPHODOXIAA 200 (Cefpodoxime Proxetil 200 mg) from Steris Healthcare Pvt. Ltd. is a reliable, broad-spectrum antibiotic used in the management of common bacterial infections. With its excellent safety profile, ease of oral administration, and clinical efficacy, it remains a preferred choice for doctors worldwide. Patients should adhere strictly to prescribed dosage and complete the treatment course to ensure optimal results and prevent antibiotic resistance.",
"price": 185.0,
"discountamount": 54.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2173,
"imageuri": "https://productimages.withfloats.com/actual/68bc22f9fc1a4c6e66f328c5.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68bc22f9fc1a4c6e66f328c5.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-09-06T12:02:48.098Z",
"updatedon": "2025-09-08T10:03:20.923Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/cephodoxiaa-200/2173",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "Cefpodoxime Proxetil Tablets IP 200 mg",
"category": "GENERAL RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68b0256b813270ffac595cb0",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "TRELAQWK 100",
"description": "TRELAQWK 100 is an advanced oral antidiabetic medication containing Trelagliptin 100 mg, specifically designed for adults with type 2 diabetes mellitus (T2DM). Belonging to the class of Dipeptidyl Peptidase-4 (DPP-4) inhibitors, this formulation helps improve blood glucose control when used along with a proper diet and regular exercise.\nWith its once-weekly dosage regimen, TRELAQWK 100 offers a convenient treatment option, enhancing patient compliance and simplifying long-term diabetes management.\nKey Ingredient\nTrelagliptin 100 mg\nA long-acting DPP-4 inhibitor that regulates blood glucose levels by enhancing incretin hormones. These incretins stimulate insulin secretion and suppress glucagon release, helping to achieve better glycemic control.\nKey Benefits of TRELAQWK 100\nWeekly dosing ensures greater convenience and adherence\nReduces both fasting and postprandial blood sugar levels\nSupports natural blood sugar regulation without weight gain\nLow risk of hypoglycemia, especially when used as monotherapy or with non-insulin therapies\nCan be prescribed as monotherapy or in combination with other antidiabetic agents like metformin or sulfonylureas\nHow TRELAQWK 100 Works\nTRELAQWK 100 functions by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).\nThese incretin hormones:\nStimulate insulin secretion in response to meals\nReduce glucagon release, lowering blood sugar levels\nThanks to its extended half-life, trelagliptin allows for once-weekly dosing, unlike other DPP-4 inhibitors that require daily administration.\nDirections for Use\nDosage: Take one tablet of TRELAQWK 100 once weekly, or as directed by your physician\nAdministration: May be taken with or without food, ideally on the same day each week\nMissed dose: Do not double the dose; consult your healthcare provider for guidance\nPossible Side Effects\nTRELAQWK 100 is usually well-tolerated, but some individuals may experience:\nMild headache\nNasopharyngitis (common cold-like symptoms)\nConstipation\nUpper respiratory tract infections\nRare skin allergies (rash, itching)\n👉 If you experience persistent abdominal pain, severe rashes, or symptoms suggestive of pancreatitis, stop the medication and seek medical care immediately.",
"price": 550.0,
"discountamount": 165.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2166,
"imageuri": "https://productimages.withfloats.com/actual/68b0256ebb42c3d551ad314c.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68b0256ebb42c3d551ad314c.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-08-28T09:46:19.602Z",
"updatedon": "2025-08-28T09:46:19.602Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-100/2166",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "trelagliptin 100 mg",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "68b02393f5434d48fca8b8ca",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "TRELAQWK 50",
"description": "TRELAQWK 50 is a modern oral antidiabetic tablet containing Trelagliptin 50 mg, specially developed for adults with type 2 diabetes mellitus. This once-weekly medication helps regulate blood sugar effectively, offering both convenience and strong clinical outcomes. With its advanced formulation, TRELAQWK 50 supports better glycemic control, making it easier for patients to lead a balanced and healthier lifestyle.\nManufactured under strict quality standards, TRELAQWK 50 ensures patient compliance, long-term safety, and efficacy in diabetes management.\nKey Ingredient\nTrelagliptin (50 mg):\nA unique, long-acting DPP-4 (dipeptidyl peptidase-4) inhibitor that allows weekly dosing, ensuring higher treatment adherence while maintaining effective control over blood glucose levels.\nKey Benefits of TRELAQWK 50\nProvides consistent blood sugar management with just one tablet per week\nEnhances insulin secretion while lowering glucagon levels in a glucose-dependent manner\nHelps reduce both fasting and postprandial blood glucose\nConvenient choice for patients with busy schedules who struggle with daily tablets\nLow risk of hypoglycemia when used as monotherapy\nSupports long-term improvement in HbA1c levels\nMechanism of Action – How TRELAQWK 50 Works\nTRELAQWK 50 works by blocking the DPP-4 enzyme, which normally degrades incretin hormones such as GLP-1 and GIP. These incretins are vital for maintaining blood sugar balance. By prolonging incretin activity, trelagliptin:\nStimulates insulin secretion from the pancreas\nReduces glucagon release from alpha cells\nHelps lower blood sugar, particularly after meals\nThis mechanism provides both effective glycemic control and improved patient compliance.\nDirections for Use\nTake one tablet of TRELAQWK 50 once a week, on the same day each week\nCan be taken with or without food\nSwallow whole with a glass of water\nFollow your doctor’s advice for dosage adjustment\nDo not double the dose if missed; consult your healthcare provider\nPossible Side Effects\nTRELAQWK 50 is usually well-tolerated. However, some patients may experience:\nMild headache\nNasopharyngitis (cold-like symptoms)\nDiarrhea\nStomach discomfort or indigestion\nRare allergic reactions (rash, itching)\nIf any unusual or persistent side effects occur, seek medical advice promptly.",
"price": 375.0,
"discountamount": 112.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2165,
"imageuri": "https://productimages.withfloats.com/actual/68b023971624ba892ffd8c69.png",
"tileimageuri": "https://productimages.withfloats.com/tile/68b023971624ba892ffd8c69.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2025-08-28T09:38:27.036Z",
"updatedon": "2025-08-28T09:38:27.036Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/trelaqwk-50/2165",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "trelagliptin 50 mg",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}